The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.

SAN FRANCISCO, Dec 1 (Reuters) - The Trump administration has agreed to take a stake in xLight - a startup seeking to develop free-electron lasers viewed as key to making faster computing chips. The U ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Pavel Gertsberg, left, and German Mikulski launched their venture to fix one of the insurance industry’s most frustrating problems. The tedious, time-consuming process of settling insurance claims is ...

Amine Mojito, the French internet personality known as Ilan M, was sentenced by the Paris Criminal Court on Oct. 3 Luke Chinman is a writer at PEOPLE. He joined PEOPLE in 2024. His work has previously ...

Mounjaro is a prescription injection that can be used to help manage blood sugar levels in adults with type 2 diabetes. It can be administered as an injection under the skin in your abdomen, thigh, or ...

Ozempic (semaglutide) is injected once weekly under the skin of your abdomen, upper arm, or thigh. Your doctor will show you how to do this before your first dose. To prevent skin issues, rotate your ...

Equinor supports Orsted's rights issue Will subscribe for shares worth up to $941 million Says it sees value in strategic collaboration with Orsted Will nominate candidate to Orsted’s board Orsted ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

VinFast to spin off R&D arm in $1.52 billion deal Founder Pham Nhat Vuong to buy shares in the R&D arm To lease back IP to VinFast as needed Aug 14 (Reuters) - VinFast's (VFS.O), opens new tab founder ...

(Reuters) -VinFast's founder Pham Nhat Vuong has agreed to buy the EV maker's research and development arm for $1.52 billion, his latest cash injection into the loss-making Vietnamese company as it ...